Aurora Cannabis Inc. (TSE:ACB - Get Free Report)'s stock price was up 8.2% during trading on Thursday . The company traded as high as C$8.72 and last traded at C$8.70. Approximately 904,213 shares traded hands during trading, a decline of 26% from the average daily volume of 1,221,178 shares. The stock had previously closed at C$8.04.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on ACB shares. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a "hold" rating to a "buy" rating and set a C$0.80 target price for the company in a research report on Friday, February 9th. CIBC cut their price target on shares of Aurora Cannabis to C$6.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 21st. Finally, Jefferies Financial Group lowered their price objective on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a "hold" rating on the stock in a report on Tuesday, February 27th.
Get Our Latest Report on ACB
Aurora Cannabis Price Performance
The company has a 50 day moving average price of C$5.23 and a 200-day moving average price of C$2.23. The company has a quick ratio of 2.48, a current ratio of 3.79 and a debt-to-equity ratio of 18.51. The company has a market cap of C$491.41 million, a price-to-earnings ratio of -0.11 and a beta of 2.83.
Aurora Cannabis (TSE:ACB - Get Free Report) last released its quarterly earnings data on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.10) by C($0.10). The firm had revenue of C$72.61 million during the quarter, compared to analyst estimates of C$63.50 million. Aurora Cannabis had a net margin of 151.71% and a negative return on equity of 137.28%. As a group, equities research analysts predict that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Further Reading
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
